Abstract
Immunotherapy in oncology is not as convenient a method, and does not solve as many problems, as was originally hoped. However, every clinician is loudly demanding improved techniques of therapy. The clinician has to evaluate any potential therapy; he or she is responsible for its effect and must find a proper balance between benefits and risks. Immunotherapy in its current guise, with biological response modifiers, cytokines, monoclonal antibodies, and autologous lymphocytes, is a promising weapon in the therapeutic armamentarium of oncology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bender, H.G. (1989). A Clinician’s Comments on Cancer Therapy with Lymphocytes. In: Koldovsky, P., Koldovsky, U., Beck, L., Vosteen, KH. (eds) Lymphocytes in Immunotherapy of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74225-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-74225-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50457-3
Online ISBN: 978-3-642-74225-5
eBook Packages: Springer Book Archive